Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
Commissioner Mariya Gabriel on COVID-19 research and innovation in Europe
EU Commissioner Mariya Gabriel shares her ambitious policy plans on the coronavirus pandemic, especially in relation to research and innovation in Europe.
Supporting the frontline against the COVID-19 pandemic
Office for Product Safety and Standards in the UK details their support of the frontline against the COVID-19 pandemic.
Diabetes increases risk of COVID-19 brain complications
New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.
COVID-19: Healthcare delivery and digital solutions
Fintan Grant, NHS Digital’s Programme Head for Medicines and Pharmacy charts the recent change in the speed of healthcare delivery in light of COVID-19 including the importance of digital solutions.
Why wear a face covering during COVID-19? The evidence
Dr Deborah Lee from Dr Fox Online Pharmacy discusses why we need to wear a face covering during the current COVID-19 pandemic, stating the evidence in this illuminating analysis.
Money troubles: Financial exclusion and COVID-19
Global financial exclusion rates are on the rise thanks to the COVID-19 crisis. Matt Adam, chief executive, We Are Digital, outlines five ways we can solve the world’s money troubles as we head back into lockdown.
Moderna vaccine: New frontrunner is 95% effective against COVID-19
Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.
The digital transformation revolution during COVID-19
Alexander Zeitelhack, Associate Dean, Berlin School of Business and Innovation charts the digital transformation revolution during COVID-19 and why it took so long to get us to the this stage.
Dementia research in the UK and COVID-19
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
The role of pharmacy during COVID-19
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
COVID-19: Solidarity is needed the most
European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.
NIH: Black and Asian people twice as likely to catch COVID-19
US and UK researchers examined ethnicity data in both countries, finding that Black and Asian people were twice as likely as white people to be infected by the virus - but why?
Can the UK’s post-COVID-19 economy benefit from a booming medical cannabis industry?
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
Diagnosis of dementia: The impact of COVID-19
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
China: How to deal with dementia during the COVID-19 pandemic
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.
Pfizer vaccine is more than 90% successful in preventing COVID-19
Created without US Government funding, the BioNTech and Pfizer vaccine is revealed to be over 90% effective against COVID-19.
Impact of COVID-19 on healthcare for patients with diabetes
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
Blood pressure medicines do not increase chance of COVID-19 death
Though heart damage plays a role in how someone deals with COVID-19, researchers at the American Heart Association found that blood pressure medicines don't impact your chances.
Researchers found that job insecurity overshadows fear of COVID-19
The study showed that fear of dwindling resources and job insecurity could distract individuals from following COVID-19 regulations for Americans across 43 states.
Recruitment during COVID-19: Managing your resources
Dr Gabriela Whitehead, Head of Digital Transformation and Process Management at GISMA Business School turns the spotlight on recruitment during COVID-19, including comment on managing resources.